Cargando…

A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial

AIMS: We explored the experiences and motivations of participants and staff who took part in the TRED‐HF trial (Therapy withdrawal in REcovered Dilated cardiomyopathy). METHODS AND RESULTS: We conducted a qualitative study, using semi‐structured interviews, with participants (n = 12) and the researc...

Descripción completa

Detalles Bibliográficos
Autores principales: Papageorgiou, Vasiliki, Jones, Kathryn, Halliday, Brian P., Mindham, Richard, Bruton, Jane, Wassall, Rebecca, Cleland, John G.F., Prasad, Sanjay K., Ward, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497205/
https://www.ncbi.nlm.nih.gov/pubmed/34390213
http://dx.doi.org/10.1002/ehf2.13524
_version_ 1784579905762099200
author Papageorgiou, Vasiliki
Jones, Kathryn
Halliday, Brian P.
Mindham, Richard
Bruton, Jane
Wassall, Rebecca
Cleland, John G.F.
Prasad, Sanjay K.
Ward, Helen
author_facet Papageorgiou, Vasiliki
Jones, Kathryn
Halliday, Brian P.
Mindham, Richard
Bruton, Jane
Wassall, Rebecca
Cleland, John G.F.
Prasad, Sanjay K.
Ward, Helen
author_sort Papageorgiou, Vasiliki
collection PubMed
description AIMS: We explored the experiences and motivations of participants and staff who took part in the TRED‐HF trial (Therapy withdrawal in REcovered Dilated cardiomyopathy). METHODS AND RESULTS: We conducted a qualitative study, using semi‐structured interviews, with participants (n = 12) and the research team (n = 4) from the TRED‐HF trial. Interviews were carried out in 2019 and were audio‐recorded and transcribed. Data were managed using NVivo and analysed using framework analysis. A patient representative provided guidance on the interpretation of findings and presentation of themes to ensure these remained meaningful, and an accurate representation, to those living with dilated cardiomyopathy. Three key themes emerged from the data: (i) perception of health; (ii) experiences and relationships with healthcare services and researchers; and (iii) perception of risk. Study participants held differing perceptions of their health; some did not consider themselves to have a heart condition or disagreed with the medical term ‘heart failure’. Relationships between participants, research staff, and clinical management teams influenced participants' experiences and decision making during the trial, including following clinical advice. There were differences in participants' perceptions of risk and their decisions to take heart failure medication after the trial was completed. Although the original TRED‐HF trial did not provide the results many had hoped for, a strong motivator for taking part was the opportunity to withdraw medication in a safely monitored environment which had been previously considered by some participants before. Investigators acknowledged that the insights gained from the study can now be used to support evidence‐based conversations with patients. CONCLUSIONS: For people whose dilated cardiomyopathy is in remission, decisions to continue, reduce, or stop their medication are influenced by perceptions of personal health, perceive risk and the important of work, employment, recreation, relationships, and long‐term plans. The unique relationship between patient and cardiologist provides opportunities to promote honest discussion about adherence to medication and personalized long‐term management.
format Online
Article
Text
id pubmed-8497205
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-84972052021-10-12 A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial Papageorgiou, Vasiliki Jones, Kathryn Halliday, Brian P. Mindham, Richard Bruton, Jane Wassall, Rebecca Cleland, John G.F. Prasad, Sanjay K. Ward, Helen ESC Heart Fail Original Research Articles AIMS: We explored the experiences and motivations of participants and staff who took part in the TRED‐HF trial (Therapy withdrawal in REcovered Dilated cardiomyopathy). METHODS AND RESULTS: We conducted a qualitative study, using semi‐structured interviews, with participants (n = 12) and the research team (n = 4) from the TRED‐HF trial. Interviews were carried out in 2019 and were audio‐recorded and transcribed. Data were managed using NVivo and analysed using framework analysis. A patient representative provided guidance on the interpretation of findings and presentation of themes to ensure these remained meaningful, and an accurate representation, to those living with dilated cardiomyopathy. Three key themes emerged from the data: (i) perception of health; (ii) experiences and relationships with healthcare services and researchers; and (iii) perception of risk. Study participants held differing perceptions of their health; some did not consider themselves to have a heart condition or disagreed with the medical term ‘heart failure’. Relationships between participants, research staff, and clinical management teams influenced participants' experiences and decision making during the trial, including following clinical advice. There were differences in participants' perceptions of risk and their decisions to take heart failure medication after the trial was completed. Although the original TRED‐HF trial did not provide the results many had hoped for, a strong motivator for taking part was the opportunity to withdraw medication in a safely monitored environment which had been previously considered by some participants before. Investigators acknowledged that the insights gained from the study can now be used to support evidence‐based conversations with patients. CONCLUSIONS: For people whose dilated cardiomyopathy is in remission, decisions to continue, reduce, or stop their medication are influenced by perceptions of personal health, perceive risk and the important of work, employment, recreation, relationships, and long‐term plans. The unique relationship between patient and cardiologist provides opportunities to promote honest discussion about adherence to medication and personalized long‐term management. John Wiley and Sons Inc. 2021-08-13 /pmc/articles/PMC8497205/ /pubmed/34390213 http://dx.doi.org/10.1002/ehf2.13524 Text en © 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research Articles
Papageorgiou, Vasiliki
Jones, Kathryn
Halliday, Brian P.
Mindham, Richard
Bruton, Jane
Wassall, Rebecca
Cleland, John G.F.
Prasad, Sanjay K.
Ward, Helen
A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial
title A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial
title_full A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial
title_fullStr A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial
title_full_unstemmed A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial
title_short A qualitative exploration of participant and investigator perspectives from the TRED‐HF trial
title_sort qualitative exploration of participant and investigator perspectives from the tred‐hf trial
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497205/
https://www.ncbi.nlm.nih.gov/pubmed/34390213
http://dx.doi.org/10.1002/ehf2.13524
work_keys_str_mv AT papageorgiouvasiliki aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT joneskathryn aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT hallidaybrianp aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT mindhamrichard aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT brutonjane aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT wassallrebecca aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT clelandjohngf aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT prasadsanjayk aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT wardhelen aqualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT papageorgiouvasiliki qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT joneskathryn qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT hallidaybrianp qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT mindhamrichard qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT brutonjane qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT wassallrebecca qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT clelandjohngf qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT prasadsanjayk qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial
AT wardhelen qualitativeexplorationofparticipantandinvestigatorperspectivesfromthetredhftrial